Loading, please wait ...
Skip


|  

News Analytics
212692 web.
Novel treatment combination for patients with BRAF-mutant metastatic colorectal cancer
EurekAlert!
Publish date unknown
The triplet combination of the BRAF inhibitor, encorafenib, MEK inhibitor, binimetinib, and EGFR inhibitor, cetuximab, significantly improves overall survival and ...
Google
#SLonardi
#MPickard
#CGuo
#CKeir
#EVanCutsem
#ClinicalInvestigator
#LAnderson
#III
#JosepTabernero
#NSteeghs
#AmandaWren
#Cetuximab
#PPfeiffer
#ESMO
#JDekervel
#JDesai
#MedicalOncologist
#MEK
#AGrothey
#FLoupakis
#YSHong
#LSTarpgaard
#EElez
#RYaeger
#BRAF
#BEACONCRC
#Results
#TKGuren
#Binimetinib
#Barcelona
#AKrishnan
#ACalvoFerrandiz
#JChristyBittel
#JTabernero
#VMorris
#TeresaMacarulla
#GastrointestinalEndocrineTumorsGroup
#HTArkenau
#KMaharry
#EGFR
#FCiardiello
#HWasan
#PGarciaAlfonso
#ElenaElez
#Encorafenib
#ESMOCongress
#SKopetz
#CorrespondingandSeniorAuthor
#TYoshino
#SOrlov
#FOLFIRI
#MBraun
#VSandor
#LBA32Encorafenib
#AGollerkeri
#VHIO
#JHMSchellens
#TWKim
#TheNewEnglandJournalofMedicineInhibitionofBRAF
#Josep

Subject Matter

  • Healthcare 61.54%
    • Hospitals, doctors and medical care 100.00%
  • Science and technology 38.46%

Emotional Reaction

Sentiment

Positive

Neutral

Negative

Definitions